Tiba Aynechi, Ph.D.
General Partner·Norwest
Tiba Aynechi, Ph.D. is a General Partner at Norwest focused on biotech. In Norwest’s Mosanna investment write-up, she backs a company developing a non-invasive bedtime nasal spray for obstructive sleep apnea and emphasizes unmet need, patient-friendly treatment, and pipeline expansion. That suggests an investing lens oriented toward differentiated biotech platforms with large patient populations and clear quality-of-life benefits.
See the rest of Tiba Aynechi, Ph.D.'s profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.